Paul Amminger

The association between stressful experiences and OCD symptoms in young adults at transdiagnostic risk.

Louise Destrée, Lucy Albertella, Laura Jobson, Patrick McGorry, Andrew Chanen, Aswin Ratheesh, Christopher Davey, Andrea Polari, Paul Amminger, Hok Pan Yuen, Jessica Hartmann, Rachael Spooner, Leonardo F Fontenelle, Barnaby Nelson

Journal article  |  2023  |  J Affect Disord

BACKGROUND: It is unclear whether there is a specific association between stressful experiences and obsessive-compulsive symptoms ..

Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosis

Subash Raj Susai, Colm Healy, David Mongan, Meike Heurich, Jonah F Byrne, Mary Cannon, Gerard Cagney, Kieran Wynne, Connie Markulev, Miriam R Schafer, Maximus Berger, Nilufar Mossaheb, Monika Schlogelhofer, Stefan Smesny, Ian B Hickie, Gregor E Berger, Eric YH Chen, Lieuwe de Haan, Dorien H Nieman, Merete Nordentoft, et al.

Journal article  |  2022  |  TRANSLATIONAL PSYCHIATRY

Preliminary evidence indicates beneficial effects of omega-3 polyunsaturated fatty acids (PUFAs) in early psychosis. The present s..

Effects of omega-3 polyunsaturated fatty acid supplementation on cognitive functioning in youth at ultra-high risk for psychosis: secondary analysis of the NEURAPRO randomised controlled trial

Nicholas Cheng, Alison McLaverty, Barnaby Nelson, Connie Markulev, Miriam R Schafer, Maximus Berger, Nilufar Mossaheb, Monika Schlogelhofer, Stefan Smesny, Ian B Hicikie, Gregor E Berger, Eric YH Chen, Lieuwe de Haan, Dorien H Nieman, Merete Nordentoft, Anita Riecher-Rossler, Swapna Verma, Rebekah Street, Andrew Thompson, Hok Pan Yuen, et al.

Journal article  |  2022  |  BJPSYCH OPEN

BACKGROUND: Cognitive impairments are well-established features of psychotic disorders and are present when individuals are at ult..

Cannabidiol for Treatment-Resistant Anxiety Disorders in Young People: An Open-Label Trial.

Maximus Berger, Emily Li, Simon Rice, Christopher G Davey, Aswin Ratheesh, Sophie Adams, Henry Jackson, Sarah Hetrick, Alexandra Parker, Tim Spelman, Richard Kevin, Iain S McGregor, Patrick McGorry, G Paul Amminger

Journal article  |  2022  |  J Clin Psychiatry

Background: Treatment resistance is a significant problem among young people experiencing moderate-to-severe anxiety, affecting ne..

Medicinal cannabis for the treatment of anxiety disorders.

Maximus Berger, G Paul Amminger, Iain S McGregor

Journal article  |  2022  |  Aust J Gen Pract

BACKGROUND: Anxiety is second most common reason for medicinal cannabis prescription in Australia and is being treated with both Δ..

Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis

Helen Baldwin, Joaquim Radua, Mathilde Antoniades, Shalaila S Haas, Sophia Frangou, Ingrid Agartz, Paul Allen, Ole A Andreassen, Kimberley Atkinson, Peter Bachman, Inmaculada Baeza, Cali F Bartholomeusz, Michael WL Chee, Tiziano Colibazzi, Rebecca E Cooper, Cheryl M Corcoran, Vanessa L Cropley, Bjorn H Ebdrup, Adriana Fortea, Louise Birkedal Glenthoj, et al.

Journal article  |  2022  |  TRANSLATIONAL PSYCHIATRY

Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profiles and outcome features. Howev..

Has improved treatment contributed to the declining rate of transition to psychosis in ultra-high-risk cohorts?

MJC Formica, LJ Phillips, JA Hartmann, AR Yung, SJ Wood, A Lin, GP Amminger, PD McGorry, B Nelson

Journal article  |  2022  |  SCHIZOPHRENIA RESEARCH

BACKGROUND: The factors contributing to declining psychotic disorder transition rates in ultra-high-risk populations remain unclea..

Machine learning based prediction and the influence of complement - Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trial

Subash Raj Susai, David Mongan, Colm Healy, Mary Cannon, Gerard Cagney, Kieran Wynne, Jonah F Byrne, Connie Markulev, Miriam R Schafer, Maximus Berger, Nilufar Mossaheb, Monika Schlogelhofer, Stefan Smesny, Ian B Hickie, Gregor E Berger, Eric YH Chen, Lieuwe de Haan, Dorien H Nieman, Merete Nordentoft, Anita Riecher-Rossler, et al.

Journal article  |  2022  |  BRAIN BEHAVIOR AND IMMUNITY

BACKGROUND: Functional outcomes are important measures in the overall clinical course of psychosis and individuals at clinical hig..

Baseline data of a sequential multiple assignment randomized trial (STEP study)

Jessica A Hartmann, Barnaby Nelson, Gunther Paul Amminger, Jessica Spark, Hok Pan Yuen, Melissa J Kerr, Andrea Polari, Nicky Wallis, Julie Blasioli, Lisa Dixon, Cameron Carter, Rachel Loewy, Tara A Niendam, Martha Shumway, Patrick D McGorry

Journal article  |  2022  |  EARLY INTERVENTION IN PSYCHIATRY

AIM: Research has shown that preventative intervention in individuals at ultra-high risk of psychosis (UHR) improves symptomatic a..

Twelve-Month Cognitive Trajectories in Individuals at Ultra-High Risk for Psychosis: A Latent Class Analysis

K Allott, SJ Schmidt, HP Yuen, SJ Wood, B Nelson, C Markulev, S Lavoie, WJ Brewer, MR Schäfer, N Mossaheb, M Schlögelhofer, S Smesny, IB Hickie, GE Berger, EYH Chen, L De Haan, DH Nieman, M Nordentoft, A Riecher-Rössler, S Verma, et al.

Journal article  |  2022  |  Schizophrenia Bulletin Open

Understanding longitudinal cognitive performance in individuals at ultra-high risk for psychosis (UHR) is important for informing ..